Prolonged agammaglobulinemia despite unaltered B-cell lymphopoiesis after peritransplant-rituximab administration in a child.
Guérin
Valérie
V
Yakouben
Karima
K
Lescoeur
Brigitte
B
Pédron
Béatrice
B
Dalle
Jean-Hugues
JH
Baruchel
André
A
Sterkers
Ghislaine
G
D000361:Agammaglobulinemia / Q000175:diagnosis* / Q000276:immunology / Q000378:metabolism; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007070:Immunoglobulin A / Q000378:metabolism; D007074:Immunoglobulin G / Q000378:metabolism; D007075:Immunoglobulin M / Q000378:metabolism; D007155:Immunologic Factors / Q000494:pharmacology*; D007223:Infant; D054429:Leukemia, Myelomonocytic, Juvenile / Q000601:surgery; D038041:Lymphopoiesis / Q000187:drug effects / Q000276:immunology*; D008297:Male; D000069283:Rituximab; D019172:Transplantation Conditioning
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007155:Immunologic Factors; D000069283:Rituximab